Home/Filings/4/0000849043-04-000057
4//SEC Filing

KRAUSE JAMES 4

Accession 0000849043-04-000057

CIK 0000849043other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 4:43 PM ET

Size

7.0 KB

Accession

0000849043-04-000057

Insider Transaction Report

Form 4
Period: 2004-05-21
KRAUSE JAMES
Senior VP Biology
Transactions
  • Award

    Stock Option (Right to Buy)

    2004-05-21+50,0000 total
    Exercise: $9.50From: 2005-05-21Common Stock .025 Par Value Per Share (50,000 underlying)
Footnotes (1)
  • [F1]On 05/21/2004 the reporting person was granted an option to purchase 50,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Stock Option Plan. The options vest in 4 equal annual installments and expire 5 years from each vesting date.

Issuer

NEUROGEN CORP

CIK 0000849043

Entity typeother

Related Parties

1
  • filerCIK 0001177841

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:43 PM ET
Size
7.0 KB